Dataset related to article "Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with Abemaciclib"
Flavia Jacobs(Fondazione IRCCS Istituto Nazionale dei Tumori), Rita De Sanctis(Humanitas University), Rosalba Torrisi(IRCCS Humanitas Research Hospital), Elisa Agostinetto(Université Libre de Bruxelles), Armando Santoro(IRCCS Humanitas Research Hospital), Alessandra Solferino(IRCCS Humanitas Research Hospital), Giovanna Masci(Humanitas University)
Cited by 0
Related Papers
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
|JAMA|2014|569
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
|The Lancet Oncology|2012|550
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532